Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysis

EJH Janssen, DET Bastiaans, PAJ Valitalo, Annemarie van Rossum, E Jacqz-Aigrain, H Lyall, CAJ Knibbe, DM Burger

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1287-1297
Number of pages11
JournalBritish Journal of Clinical Pharmacology
Volume83
Issue number6
DOIs
Publication statusPublished - 2017

Research programs

  • EMC MM-04-54-08-A

Cite this